Association Between PDL1 Genetic Variation and Efficacy of Apatinib Monotherapy in Patients with Previously Treated Advanced NSCLC: A Real-World Retrospective Study-Reference-Cited by-同舟云学术

Association Between PDL1 Genetic Variation and Efficacy of Apatinib Monotherapy in Patients with Previously Treated Advanced NSCLC: A Real-World Retrospective Study

Published:2021-06 Issue: Volume:Volume 14 Page:2703-2714
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Hu Wenxia,Li Bin,Geng Nan^ORCID,He Xin,Ge Hui,Wang Ping,Ding Cuimin

Publisher

Informa UK Limited

Subject

General Medicine

Reference38 articles.

1. Progress of exosomes in the diagnosis and treatment of lung cancer

Clinical Significance of Has_circ_0060937 in Bone Metastasis of NSCLC

3. The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small-cell lung cancer patients treated with EGFR TKI

4. Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

5. First-line management of metastatic non-small cell lung cancer: An Indian perspective

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility;International Immunopharmacology;2023-12

2. Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade;International Immunopharmacology;2023-08

3. The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial;Frontiers in Oncology;2022-11-23

4. Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study;Journal of Oncology;2022-07-22

5. A Genetic Variant in CD274 Is Associated With Prognosis in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Based Chemotherapy;Frontiers in Oncology;2022-06-28